C-Rad Beheer

Beheer criteriumcontroles 1/4

De CEO C-Rad is Cecilia de Leeuw, benoemd in Dec2022, heeft een ambtstermijn van 1.92 jaar. De totale jaarlijkse vergoeding van { bedraagt SEK 2.98M, bestaande uit 70.4% salaris en 29.6% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.042% van de aandelen van het bedrijf, ter waarde SEK 399.67K. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 1.9 jaar en 1.5 jaar.

Belangrijke informatie

Cecilia de Leeuw

Algemeen directeur

SEK 3.0m

Totale compensatie

Percentage CEO-salaris	70.4%
Dienstverband CEO	1.9yrs
Eigendom CEO	0.04%
Management gemiddelde ambtstermijn	1.9yrs
Gemiddelde ambtstermijn bestuur	1.5yrs

Recente managementupdates

Recent updates

Analyse CEO-vergoeding

Hoe is Cecilia de Leeuw's beloning veranderd ten opzichte van C-Rad's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Sep 30 2024	n/a	n/a	SEK 58m
Jun 30 2024	n/a	n/a	SEK 54m
Mar 31 2024	n/a	n/a	SEK 48m
Dec 31 2023	SEK 3m	SEK 2m	SEK 36m
Sep 30 2023	n/a	n/a	SEK 24m
Jun 30 2023	n/a	n/a	SEK 20m
Mar 31 2023	n/a	n/a	SEK 12m
Dec 31 2022	SEK 839k	SEK 175k	SEK 7m

Compensatie versus markt: De totale vergoeding ($USD 271.12K ) Cecilia } is ongeveer het gemiddelde voor bedrijven van vergelijkbare omvang in de UK markt ($USD 354.57K ).

Compensatie versus inkomsten: De vergoeding van Cecilia is het afgelopen jaar met meer dan 20% gestegen.

CEO

Cecilia de Leeuw (56 yo)

1.9yrs

Tenure

SEK 2,981,000

Compensatie

Ms. Cecilia de Leeuw was Director of Kambi Group plc since May 16, 2019 until May 22, 2024. She is an Independent Director of Net Insight AB (publ) since May 2022. She is Chief Executive Officer of C-Rad A...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Cecilia de Leeuw	CEO & President	1.9yrs	SEK 2.98m	0.042% SEK 399.7k
Linda Frölén	Chief Financial Officer	less than a year	geen gegevens	geen gegevens
Hakan Axelsson	Chief Operating Officer	5.3yrs	geen gegevens	geen gegevens
Greta Cattani	Global Marketing Director	1.2yrs	geen gegevens	geen gegevens
Anna Aman	Human Resource Manager	less than a year	geen gegevens	geen gegevens
Xiaodong Wang	President of C-RAD China	6.8yrs	geen gegevens	0.12% SEK 1.1m
Ivan Astralaga	President of C-RAD Americas	3.5yrs	geen gegevens	geen gegevens
Basak Karakus	Executive for Global Digital Marketing	no data	geen gegevens	geen gegevens

1.9yrs

Gemiddelde duur

50.5yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van 0R44 wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 1.9 jaar), wat duidt op een nieuw team.

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Kristina Willgard	Independent Chair of the Board	1.5yrs	SEK 280.00k	0.030% SEK 285.5k
Mats Thoren	Independent Director	less than a year	geen gegevens	geen gegevens
Jenny Rosberg	Independent Director	3.8yrs	SEK 255.00k	0.051% SEK 485.4k
Susanne Ekblom	Independent Director	1.5yrs	SEK 160.00k	geen gegevens
Peter Simonsbacka	Independent Director	1.5yrs	SEK 147.00k	geen gegevens
David Sjostrom	Independent Director	7.5yrs	SEK 220.00k	geen gegevens

1.5yrs

Gemiddelde duur

58yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van 0R44 wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 1.5 jaar), wat duidt op een nieuw bestuur.

C-Rad Beheer

Beheer criteriumcontroles 1/4

Belangrijke informatie

Recente managementupdates

Independent Director recently bought kr190k worth of stock

CEO & President recently bought kr85k worth of stock

C-Rad AB (publ) Appoints Mats Thorén as Board Member

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Recent updates

C-Rad AB (publ) to Report Q3, 2025 Results on Oct 23, 2025

Independent Director recently bought kr190k worth of stock

New minor risk - Market cap size

Third quarter 2024 earnings released: EPS: kr0.45 (vs kr0.32 in 3Q 2023)

CEO & President recently bought kr85k worth of stock

Second quarter 2024 earnings released: EPS: kr0.31 (vs kr0.16 in 2Q 2023)

Full year 2023 earnings released: EPS: kr1.05 (vs kr0.22 in FY 2022)

C-Rad AB (publ) Appoints Mats Thorén as Board Member

C-Rad AB (publ) to Report Fiscal Year 2023 Results on Apr 23, 2024

Full year 2023 earnings released: EPS: kr1.36 (vs kr0.22 in FY 2022)

C-Rad AB (publ) to Report Q3, 2024 Results on Oct 23, 2024

Third quarter 2023 earnings released

Investor sentiment improves as stock rises 17%

Less than half of directors are independent

C-Rad AB (Publ) Announces Former Employee Appeals Verdict from the Patent and Market Court of Appeal

New major risk - Earnings quality

C-Rad AB (publ) to Demonstrate Enhancements in Surface Guided Solutions for Advanced Radiotherapy Treatments at AAPM

Second quarter 2023 earnings released

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

C-Rad AB (publ) to Report Fiscal Year 2022 Final Results on Apr 06, 2023

C-Rad AB (Publ) Appoints Christoffer Herou as CFO

C-Rad AB (Publ) Announces CEO Changes

C-Rad AB (publ) Announces CFO Changes

C-Rad AB (publ) to Report Q3, 2023 Results on Oct 27, 2023

C-RAD Launches New Updated eDucation Portal as an Online Platform

Second quarter 2022 earnings released

Henrik Bergentoft Resigns as CFO of C-RAD

C-Rad Announces CEO Changes

Insufficient new directors

Insufficient new directors

C-Rad AB (publ) to Report Q3, 2022 Results on Oct 28, 2022

C-Rad Achieves Another Milestone Ensuring the Availability of SGRT, the Standard of Care for Radiotherapy

Third quarter 2021 earnings released

Chief Operating Officer recently sold kr625k worth of stock

Second quarter 2021 earnings released

C-Rad AB (publ) Announces The Patent and Market Court Rejected Former Employee Claim for Compensation

The Patent and Market Court of Appeal Issues Judgement Confirming C-Rad's Entitlement to Beamocular's Invention

Full year 2020 earnings released: EPS kr0.43 (vs kr0.45 loss in FY 2019)

C-RAD and Alliance Radiation Oncology Announce That Alliance Has Become the First Center in the Greater Northshore Area to Integrate C-Rad

C-Rad and With-Global Engages in a Partnership for the South Korean Market

C-RAD Receives Order for Proton Cancer Treatment Centers in the US

Shenzhen Proton Therapy Treatment Center Selects C-Rad Catalyst™ System

C-Rad AB (publ) to Report Q2, 2021 Results on Jul 29, 2021

Shanghai Proton and Heavy Ion Hospital Decides for C-Rad Sigrt Solution

Australian Customers Select C-RAD’s Cutting Edge SIGRT Solution

C-Rad AB Receives SEK 11 Million Order for Cutting Edge SIGRT Solution by DTZ in Berlin

Independent Director recently sold kr672.4k worth of stock

Independent Director recently bought kr1.7m worth of stock

Independent Director recently sold kr3.4m worth of stock

Analyse CEO-vergoeding

CEO

Tenure

Compensatie

Leiderschapsteam

Gemiddelde duur

Gemiddelde leeftijd

Bestuursleden

Gemiddelde duur

Gemiddelde leeftijd